HCW Biologics Inc.
NASDAQ:HCWB
7.4 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 4.675 | 3.595 | 22.326 | 11.731 | 8.456 | 7.356 |
| Short Term Investments
| 0 | 0 | 9.736 | 24.984 | 0 | 0 |
| Cash and Short Term Investments
| 4.675 | 3.595 | 32.062 | 36.714 | 8.456 | 7.356 |
| Net Receivables
| 0.582 | 1.536 | 0.418 | 0.133 | 2.5 | 0 |
| Inventory
| 0 | 0 | 1.395 | 2.197 | 0.538 | 0 |
| Other Current Assets
| 0.442 | 1.273 | 1.591 | 3.633 | 1.193 | 0.674 |
| Total Current Assets
| 5.698 | 6.404 | 34.071 | 40.48 | 12.149 | 8.03 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 22.91 | 20.453 | 10.805 | 1.119 | 1.615 | 2.002 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.6 | 1.6 | 1.6 | 11.522 | 1.6 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.028 | 0.057 | 0.334 | 0.393 | 0.034 | 0.034 |
| Total Non-Current Assets
| 24.538 | 22.109 | 12.738 | 13.034 | 3.249 | 2.036 |
| Total Assets
| 30.237 | 28.514 | 46.809 | 53.515 | 15.398 | 10.066 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 22.332 | 6.167 | 1.226 | 0.224 | 0.155 | 0.392 |
| Short Term Debt
| 6.315 | 0 | 0 | 0 | 0.567 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 1.8 | -0.567 | 0 |
| Other Current Liabilities
| 0.982 | 2.58 | 1.73 | 2.098 | 0.278 | 0.674 |
| Total Current Liabilities
| 29.629 | 8.748 | 2.956 | 2.322 | 1.001 | 1.066 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 6.304 | 6.41 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.378 | 0 | 0.014 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 7.378 | 6.304 | 6.424 | 0 | 0 | 0 |
| Total Liabilities
| 37.007 | 15.052 | 9.381 | 2.322 | 1.001 | 1.066 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 53.515 | 31.115 | 18.676 |
| Common Stock
| 0.004 | 0.004 | 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -100.556 | -70.532 | -45.538 | -30.637 | -16.719 | -9.677 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -53.515 | -0.001 | -0.001 |
| Other Total Stockholders Equity
| 93.782 | 83.99 | 82.963 | 28.312 | 0 | 0 |
| Total Shareholders Equity
| -6.77 | 13.462 | 37.429 | 51.193 | 14.397 | 9 |
| Total Equity
| -6.77 | 13.462 | 37.429 | 51.193 | 14.397 | 9 |
| Total Liabilities & Shareholders Equity
| 30.237 | 28.514 | 46.809 | 53.515 | 15.398 | 10.066 |